title: New adoptive immunotherapy strategies for solid tumours with CIK cells.
abstract: BACKGROUND
  Despite development and introduction of new and innovative drugs, a large number of malignant diseases are associated with unfavourable prognosis. In recent years, considerable progress in cancer treatment has been obtained by the application of cytokine-induced killer (CIK) cells.
  
  
  METHODS
  This review provides an overview and summary of recent advances in adoptive immunotherapy strategies in cancer treatment using CIK cells. A selective literature search has been performed.
  
  
  CONCLUSIONS
  The application of CIK cells as adoptive immunotherapy plays an important role in cancer treatment. Combining CIK cells with other conventional and established therapy options represents an innovative approach and will hopefully provide new insight for the future.
authors.affiliation: Department of Internal Medicine III, University of Bonn, Bonn, Germany. Ingo.Schmidt-Wolf@ukb.uni-bonn.de
authors.forename: Sharmilan
authors.initials: S
authors.lastname: Thanendrarajan
authors.forename: Young
authors.initials: Y
authors.lastname: Kim
authors.forename: Ingo
authors.initials: I
authors.lastname: Schmidt-Wolf
mesh_terms: D002986:Clinical Trials as Topic; D016207:Cytokines / Q000276:immunology*; D006801:Humans; D016219:Immunotherapy, Adoptive; D008214:Lymphocytes / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
chemical_list: D016207:Cytokines